UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014676
Receipt number R000017069
Scientific Title The deficits in prefrontal cortex functions in depression and the therapeutic efficacy of the attention training technique.
Date of disclosure of the study information 2014/08/01
Last modified on 2024/02/28 11:38:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The deficits in prefrontal cortex functions in depression and the therapeutic efficacy of the attention training technique.

Acronym

The deficits in prefrontal cortex functions in depression and the therapeutic efficacy of the attention training technique.

Scientific Title

The deficits in prefrontal cortex functions in depression and the therapeutic efficacy of the attention training technique.

Scientific Title:Acronym

The deficits in prefrontal cortex functions in depression and the therapeutic efficacy of the attention training technique.

Region

Japan


Condition

Condition

Major depressive disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The first aim of this study is to confirm the effect of ATT on alleviating depression symptoms, including rumination, and its effectiveness on preventing the recurrence of depression. The second aim is to reveal the functional deficits of the prefrontal cortex in depression, and to verify how much that could be improved by practicing ATT.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The Hamilton Rating Scale for Depression
Beck Depression Inventory
Montgomery-Asberg Depression Rating Scale
Meta-cognitions Questionnaire-30
Detached Mindfulness Mode Questionnaire

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Intervention of the ATT( attention training technique) is usually performed for 8 weeks in treatment.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Those who were diagnosed as major depression disorder using the Structured Clinical Interviews for DSM-5(SCID-1).

Key exclusion criteria

Atypical features, bipolar disorders, psychotic disorders, substance-related disorders, personality disorders, comorbid with or having any history of dementia, dosing tricyclic antidepressant drugs

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takamasa
Middle name
Last name Noda

Organization

National Center Hospital, National Center of Neurology and Psychiatry

Division name

Department of Psychiatry

Zip code

187-8551

Address

1-1-4 Ogawa-Higashi-Cho, Kodaira-Shi, Tokyo, 187-8551

TEL

0423412711

Email

t-noda@ncnp.go.jp


Public contact

Name of contact person

1st name Shiori
Middle name
Last name Setoyama

Organization

National Center Hospital, National Center of Neurology and Psychiatry

Division name

Department of Psychiatry

Zip code

187-8551

Address

1-1-4 Ogawa-Higashi-Cho, Kodaira-Shi, Tokyo, 187-8551

TEL

042-341-2711

Homepage URL


Email

nodat_labo@ncnp.go.jp


Sponsor or person

Institute

Faculty of HumanSciences, WASEDA University

Institute

Department

Personal name



Funding Source

Organization

Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board, National Center of Neurology and Psychiatry

Address

1-1-4 Ogawa-Higashi-Cho, Kodaira-Shi, Tokyo, 187-8551

Tel

042-341-2711

Email

irb-office@ncnp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立研究開発法人国立精神・神経医療研究センター病院(東京都)


Other administrative information

Date of disclosure of the study information

2014 Year 08 Month 01 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000017069

Publication of results

Unpublished


Result

URL related to results and publications

https://kaken.nii.ac.jp/file/KAKENHI-PROJECT-25461790/25461790seika.pdf

Number of participants that the trial has enrolled

42

Results

Tests on healthy subjects indicated attentional function training might enhance attentional control and alleviate depression. Subsequently, ATT was applied for 7 weeks on 10 major depression patients, reducing negative rumination, anxiety, and enhancing divided attention. Depressive symptoms decreased, and "distanced attentiveness" (DM) improved. Brain function indicators revealed increased cerebral blood flow in specific regions correlated with enhanced attention control.

Results date posted

2024 Year 02 Month 28 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Subjects were patients with major depressive disorder and healthy subjects aged 16 years and older.
The patient group was diagnosed using the Psychiatric Diagnostic Interview (SCID).
[Exclusion criteria]
Things with atypical characteristics
Those with comorbidity or history of bipolar disorder, psychotic disorder, substance-related disorder, personality disorder, or dementia
Taking tricyclic antidepressants
[Cancellation criteria]
If the patient group worsens by two or more levels on the CGI-S during the intervention period, the intervention will be discontinued.
If healthy subjects become unwell, the intervention will be discontinued at the discretion of a physician.

Participant flow

Of the 42 patients who consented to participate in the study, 16 patients in the patient group and 26 in the healthy group participated in the study. The patient group participated in an open study, and all patients were in the intervention group. The healthy subjects participated in the RCT study, with 13 patients in the intervention group and 13 patients in the control group. In the patient group, 2 patients dropped out and 4 patients had unanalyzable data, so the analysis target population was 10 patients. The analysis target population of the healthy group was 26 cases.

Adverse events

None

Outcome measures

[Biological indicators]
Cerebral blood flow test using optical topography device (NIRS)
Word fluency task (VFT) and dichotic listening task (DLT)
Magnetic resonance imaging (MRI)
3D structural images, resting brain activity, flare images, DTI, ASL
[Psychiatric symptom evaluation]
Hamilton Depression Rating Scale (HAM-D/HDS)
Young Mania Rating Scale Japanese version (YMRS-J)
Montgomery Asberg Depression Rating Scale (MADRS)
Japanese version of Beck Depression Questionnaire 2nd edition (BDI-2)
State/Trait Anxiety Test (STAI-S, T)
[Cognitive/attention function evaluation]
Attention control function measurement scale
Negative rumination scale
Japanese version of MCQ (scale to measure metacognitive beliefs)
DMMQ (scale to measure detached mindfulness)

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 06 Month 27 Day

Date of IRB

2012 Year 06 Month 04 Day

Anticipated trial start date

2014 Year 08 Month 12 Day

Last follow-up date

2016 Year 06 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 07 Month 28 Day

Last modified on

2024 Year 02 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017069


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name